One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Multiplex Assays Market

[ 英語タイトル ] Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User (Pharma & Biotech, Reference Laboratory, Hospital) - Global Forecast to 2023


Product Code : MNMHC00109895
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global multiplex assays market is projected to grow at a CAGR of 7.5%.”
The global multiplex assays market is projected to reach USD 3.35 billion in 2023 from USD 2.33 billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. However, the high cost of multiplex assay equipment & standardization of immunoassay design and quality control are the major factors expected to restrain market growth.

“The pharmaceutical and biotechnology segment is expected to account for the largest share in 2018.”
On the basis of end user, the global multiplex assays market is divided into pharmaceutical and biotechnology companies, hospitals & academic research institutes, reference laboratories, and other end users. In 2018, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increased adoption of multiplex assays in drug discovery & development by pharmaceuticals and the growing focus of biotechnology companies on developing biosimilars and monoclonal antibodies.
“North America is expected to account for the largest share of the market in 2018.”
By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe. The dominant share of North American market is primarily attributed to its established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investment.

Break-up profile of primaries:
• By Company Type- Tier 1-42%, Tier 2-37% and Tier 3-21%
• By Designation- C-level-34%, D-level-42% and Others-24%
• By Region- North America-32%, Europe-30%, Asia Pacific-24%, and RoW-14%
The key players in the multiplex assays market are Luminex (US), Bio-Rad Laboratories (US), Becton, Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US).

Research Coverage:
The multiplex assays market in this report is segmented by product & services, type, technology, application, and end user. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the multiplex assays market.
Reasons to buy this report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on portfolios offered by the top players in the global multiplex assays market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global multiplex assays market
• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for multiplex assays products across regions
• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global multiplex assays market
• Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global multiplex assays market

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 PRIMARY DATA 17
2.1.1 KEY DATA FROM PRIMARY SOURCES 17
2.1.2 KEY INDUSTRY INSIGHTS 18
2.2 SECONDARY DATA 19
2.2.1 KEY DATA FROM SECONDARY SOURCES 19
2.3 MARKET SIZE ESTIMATION 20
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.4.1 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 MULTIPLEX ASSAYS MARKET OVERVIEW 28
4.2 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION AND COUNTRY (2018) 29
4.3 MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE (2018 VS. 2023) 29
4.4 GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.2.1 DRIVERS 32
5.2.1.1 Use of multiplex assays in companion diagnostics 32
5.2.1.2 Advantages over singleplex and traditional assays 32
5.2.2 RESTRAINTS 32
5.2.2.1 High equipment costs 32
5.2.2.2 Stringent regulations and standards 33

5.2.3 OPPORTUNITIES 33
5.2.3.1 Increasing validation of biomarkers in molecular and protein diagnostics 33
5.2.3.2 Need for high-throughput and automated systems 33
6 MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE 34
6.1 INTRODUCTION 35
6.2 CONSUMABLES 35
6.3 INSTRUMENTS 37
6.4 SOFTWARE AND SERVICES 38
7 MULTIPLEX ASSAYS MARKET, BY TYPE 39
7.1 INTRODUCTION 40
7.2 PROTEIN MULTIPLEX ASSAYS 40
7.2.1 PLANAR PROTEIN ASSAYS 42
7.2.2 BEAD-BASED PROTEIN ASSAYS 43
7.2.3 OTHER PROTEIN ASSAYS 44
7.3 NUCLEIC ACID MULTIPLEX ASSAYS 45
7.3.1 PLANAR NUCLEIC ACID ASSAYS 46
7.3.2 BEAD-BASED NUCLEIC ACID ASSAYS 47
7.3.3 OTHER NUCLEIC ACID ASSAYS 48
7.4 CELL-BASED MULTIPLEX ASSAYS 49
8 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY 51
8.1 INTRODUCTION 52
8.2 FLOW CYTOMETRY 52
8.3 FLUORESCENCE DETECTION 54
8.4 LUMINESCENCE 55
8.5 MULTIPLEX REAL-TIME PCR 56
8.6 OTHER TECHNOLOGIES 57
9 MULTIPLEX ASSAYS MARKET, BY APPLICATION 59
9.1 INTRODUCTION 60
9.2 RESEARCH & DEVELOPMENT 60
9.2.1 DRUG DISCOVERY & DEVELOPMENT 61
9.2.2 BIOMARKER DISCOVERY & VALIDATION 62
9.3 CLINICAL DIAGNOSTICS 64
9.3.1 INFECTIOUS DISEASES 65
9.3.2 CANCER 66
9.3.3 CARDIOVASCULAR DISEASES 67
9.3.4 AUTOIMMUNE DISEASES 68
9.3.5 NERVOUS SYSTEM DISORDERS 69
9.3.6 METABOLISM & ENDOCRINOLOGY DISORDERS 70
9.3.7 OTHER DISEASES 71
10 MULTIPLEX ASSAYS MARKET, BY END USER 73
10.1 INTRODUCTION 74
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 74
10.3 HOSPITALS & RESEARCH INSTITUTES 76
10.4 REFERENCE LABORATORIES 77
10.5 OTHER END USERS 78
11 MULTIPLEX ASSAYS MARKET, BY REGION 79
11.1 INTRODUCTION 80
11.2 NORTH AMERICA 81
11.2.1 US 85
11.2.2 CANADA 87
11.3 EUROPE 90
11.4 ASIA PACIFIC 92
11.5 REST OF THE WORLD 96
12 COMPETITIVE LANDSCAPE 98
12.1 OVERVIEW 98
12.2 MARKET RANKING ANALYSIS, 2017 99
12.3 COMPETITIVE SITUATION AND TRENDS 100
12.3.1 PRODUCT LAUNCHES AND APPROVALS 100
12.3.2 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS 100
12.3.3 ACQUISITIONS 101
13 COMPANY PROFILES 102
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 LUMINEX 102
13.2 THERMO FISHER SCIENTIFIC 106
13.3 ILLUMINA 109
13.4 BIO-RAD LABORATORIES 112
13.5 QIAGEN 114
13.6 ABCAM 116
13.7 BECTON DICKINSON AND COMPANY 118
13.8 MERCK 120
13.9 AGILENT TECHNOLOGIES 122
13.10 MESO SCALE DIAGNOSTICS 124
13.11 RANDOX LABORATORIES 125
13.12 QUANTERIX 126

13.13 BIO-TECHNE 128
13.14 OLINK 130
13.15 SEEGENE 131

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14 APPENDIX 133
14.1 INSIGHTS OF INDUSTRY EXPERTS 133
14.2 DISCUSSION GUIDE 134
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 140
14.5 AVAILABLE CUSTOMIZATIONS 141
14.6 RELATED REPORTS 141
14.7 AUTHOR DETAILS 142

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+